Gut microbiota dysbiosis promotes aortic aneurysm and dissection through FPR1-driven vascular inflammation
Ontology highlight
ABSTRACT: Aortic aneurysm and dissection (AAD) are life-threatening cardiovascular disorders for which effective preventive strategies remain limited. Although the gut microbiota is recognized as a critical modulator of multiple cardiovascular diseases, its role in AAD remains unclear. Using microbiome sequencing, we identified gut microbiota dysbiosis in AAD patients, characterized by the expansion of Escherichia coli (E. coli). Further evidence indicates that E. coli is a key AAD-promoting strain, exacerbating aortic inflammation. Moreover, through transcriptomic profiling and high-performance liquid chromatography-mass spectrometry analyses, E. coli-derived fMLF was identified as a microbial metabolite that promotes AAD progression via formyl peptide receptor 1 (FPR1). Mechanistically, FPR1 is activated by fMLF in macrophages, enhancing macrophage chemotaxis and the proinflammatory responses through the p38/ERK MAPK signaling pathways. These findings confirm the crucial role of the gut microbiota and its metabolites in the pathogenesis of AAD, and provide insights for developing effective preventive and therapeutic strategies for AAD.
ORGANISM(S): Mus Musculus
SUBMITTER:
Tingtao Chen
PROVIDER: PXD075915 | iProX | Fri Mar 20 00:00:00 GMT 2026
REPOSITORIES: iProX
ACCESS DATA